PBI2 Real-World Evaluation of Biosimilar Bevacizumab-awwb versus Reference Bevacizumab in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer in a U.S. Integrated Healthcare Delivery System: 6-Month Interim Analysis
Abstract
Authors
C. Pham E. Ekinci T. Chiu F. Niu T. Delate E. McGary J.M. Suga K. Le R. Hui